Search research articles
Contact Us
Filters
Showing results (381-390 of 417) with videos related to
Page
of 42
Sort By:
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]
|
June 28, 2022
The occurrence of antimicrobial residues and antimicrobial resistance genes in urban drinking water and sewage in Southern Brazil
Rafaela Ramalho, Lisiane Cervieri Mezzomo, William Machado, et al.
Clinical Epigenetics
|
October 4, 2021
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status
Philipp Jurmeister, Karsten Weber, Sonia Villegas, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]
|
October 18, 2017
In vitro antimicrobial and antimycobacterial activity and HPLC-DAD screening of phenolics from Chenopodium ambrosioides L
Roberta S Jesus, Mariana Piana, Robson B Freitas, et al.
Infection
|
February 14, 2023
Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality
Marietta Jank, Anna-Lisa Oechsle, Jakob Armann, et al.
Neoplasia (New York, N.Y.)
|
September 13, 2023
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
Inga Hoffmann, Mihnea P Dragomir, Nanna Monjé, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging
Juliana Pereira Lopes Gonçalves, Christine Bollwein, Aurelia Noske, et al.
Journal of Ovarian Research
|
July 31, 2023
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
Paul Jank, Jonas Leichsenring, Svenja Kolb, et al.
International Journal of Cancer
|
December 20, 2021
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease
Anja Kathrin Wege, Eva-Maria Rom-Jurek, Paul Jank, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 14, 2021
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial
A Llop-Guevara, S Loibl, G Villacampa, et al.
Signal Transduction and Targeted Therapy
|
March 21, 2025
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
Niklas Gremke, Isabelle Besong, Alina Stroh, et al.
Page
of 42
Search research articles
Search
Showing results (381-390 of 417) with videos related to
Sort By:
Page
of 42
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]
|
June 28, 2022
The occurrence of antimicrobial residues and antimicrobial resistance genes in urban drinking water and sewage in Southern Brazil
Rafaela Ramalho, Lisiane Cervieri Mezzomo, William Machado, et al.
Clinical Epigenetics
|
October 4, 2021
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status
Philipp Jurmeister, Karsten Weber, Sonia Villegas, et al.
Brazilian Journal of Microbiology : [Publication of the Brazilian Society for Microbiology]
|
October 18, 2017
In vitro antimicrobial and antimycobacterial activity and HPLC-DAD screening of phenolics from Chenopodium ambrosioides L
Roberta S Jesus, Mariana Piana, Robson B Freitas, et al.
Infection
|
February 14, 2023
Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality
Marietta Jank, Anna-Lisa Oechsle, Jakob Armann, et al.
Neoplasia (New York, N.Y.)
|
September 13, 2023
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
Inga Hoffmann, Mihnea P Dragomir, Nanna Monjé, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Characterization of Hormone Receptor and HER2 Status in Breast Cancer Using Mass Spectrometry Imaging
Juliana Pereira Lopes Gonçalves, Christine Bollwein, Aurelia Noske, et al.
Journal of Ovarian Research
|
July 31, 2023
High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
Paul Jank, Jonas Leichsenring, Svenja Kolb, et al.
International Journal of Cancer
|
December 20, 2021
mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease
Anja Kathrin Wege, Eva-Maria Rom-Jurek, Paul Jank, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 14, 2021
Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial
A Llop-Guevara, S Loibl, G Villacampa, et al.
Signal Transduction and Targeted Therapy
|
March 21, 2025
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
Niklas Gremke, Isabelle Besong, Alina Stroh, et al.
Page
of 42